Staphylococcal Infections
📧 Sign up to get email alerts when something new happens for Staphylococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida [Phase 1]
Phase 1 safety and immunogenicity study of the recombinant NDV-3 vaccine targeting Staphylococcus aureus and Candida infections has been com…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates [Phase 2]
Phase 2 safety study of Altastaph, intravenous Staphylococcus aureus immune globulin (human), in low-birth-weight neonates has been complete…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Evaluation of Consistency of StaphVAX Manufacturing Lots [Phase 3]
Phase 3 trial update evaluating the consistency of StaphVAX manufacturing lots. The study status is COMPLETED.
-
FDA approval · 2011-06-30FDA Approved: NAFCILLIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Nafcillin sodium (NAFCILLIN SODIUM) as a generic injectable antibiotic from Fresenius Kabi USA, LL…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection [Phase 4]
Open-label, non-comparative Phase 4 study evaluating tigecycline for catheter-related Staphylococcal infections.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections [Phase 4]
Phase 4 clinical trial evaluating intranasal mupirocin for prevention of Staphylococcus aureus infections; study completed.
-
FDA approval · 2008-12-30FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved the original application for vancomycin hydrochloride from Mylan Institutional LLC, marking the approval of a generic injectabl…
-
EMA withdrawal · 2008-10-24EMA Application withdrawn: Vibativ (telavancin) — Astellas Pharma Europe B. V.
EMA withdrew the application for Vibativ (telavancin) by Astellas Pharma Europe B. V.; therapeutic areas include skin infections and staphyl…
-
EMA withdrawal · 2008-09-10EMA Application withdrawn: Exulett — Pfizer Limited
EMA reports withdrawal of the Exulett application by Pfizer Limited for skin and soft tissue infections and staphylococcal infections.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus [NA]
Completed clinical trial evaluating vancomycin for treating catheter-related bloodstream infections caused by coagulase-negative Staphylococ…
-
CLINICAL_TRIALS research · 2008-03-31Clinical Trial Update: Preoperative Nasal Swabs From Pediatric Patients
This clinical trial update describes preoperative nasal swab collection from pediatric patients to assess Staphylococcal infections; the tri…
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: StaphVAX in Cardiovascular Surgery Patients [Phase 3]
A Phase 3 trial evaluating StaphVAX in cardiovascular surgery patients has completed. The trial assessed outcomes related to preventing Stap…
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: StaphVAX Immunogenicity in Orthopedic Implant Patients [Phase 3]
A Phase 3 trial update reporting immunogenicity data for StaphVAX in patients with orthopedic implants; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease [Phase 3]
Phase 3 trial evaluating a third and fourth dose of StaphVAX in adults with end-stage renal disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of StaphVAX in orthopaedic joint surgery has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: Evaluation of Manufacturing Lot of StaphVAX [Phase 3]
Phase 3 trial update describing evaluation of a manufacturing lot for StaphVAX; the study status is completed.
-
CLINICAL_TRIALS research · 2007-08-20Clinical Trial Update: Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
An update on a clinical trial conducted by the University of Sao Paulo studying Staphylococcus aureus carriers among nursing students, focus…
-
CLINICAL_TRIALS trial_result · 2006-09-19Clinical Trial Update: Aurograb and Vancomycin in MRSA Infection [Phase 3]
A Phase 3 trial evaluating Aurograb with vancomycin for MRSA-related staphylococcal infections has completed.
-
CLINICAL_TRIALS research · 2006-08-24Clinical Trial Update: A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely [Phase 4]
A Phase 4 clinical trial update evaluating the loading dose of teicoplanin needed to quickly achieve therapeutic serum concentrations in pat…
-
CLINICAL_TRIALS trial_result · 2006-07-11Clinical Trial Update: Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis [Phase 3]
A Phase 3 trial evaluating StaphVAX in adults on hemodialysis has completed.